Do not invest unless you are prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
The Parkwalk Knowledge Intensive EIS Fund IV is closing on Friday 4th April, so this is your last chance to lock in income tax relief carry back to 2023/24. The fund provides the opportunity to invest in a diversified portfolio of 10+ high-growth university spinouts while benefiting from valuable EIS tax reliefs.
Key reasons to invest in the Knowledge Intensive EIS Fund IV:
- Income tax relief for 2024/25
- Carry-back option to 2023/24
- Diversified exposure to 10+ university spinout companies across deeptech and science and varying stages
- Reduced administration – one EIS5 certificate at the end of the fund’s deployment period, with a target of 12-18 months deployment
What sets Parkwalk apart from other funds?
- Proven technology – We back cutting-edge innovation developed by some of the brightest minds in the UK, across sectors such as quantum computing, AI, digital health and life sciences.
- Unmatched deal flow – Our unique access to the UK’s top universities provides a pipeline of high-quality companies, allowing us to select the most promising investment opportunities.
- 15-year performance track record – With a strong history of delivering results, our first KI Fund has already delivered a positive exit.
As the UK’s largest EIS fund manager, we’ve deployed over £500m into more than 180 companies, generating cash returns of over £160m. Our investment team’s expertise in identifying and supporting high-potential companies has consistently delivered strong returns alongside the valuable tax benefits provided under the EIS.
How to apply
To find out more about the Parkwalk Knowledge Intensive EIS Fund IV, please reach out to the team on [email protected] or call 020 7759 2285.
Parkwalk Advisors Limited (Parkwalk) is authorised and regulated by the Financial Conduct Authority: FRN 502237. Investments referred to in this news article are not suitable for all investors. Capital is at risk and investors may not get back the full amount invested. Any investment in a Parkwalk product must only be made on the basis of the terms of the full Information Memorandum. Tax treatment depends on the individual circumstances of each investor. Parkwalk is not able to provide advice as to the suitability of investing in any product. Past performance is not a reliable indicator of future results. This financial promotion was approved in March 2025.
